Xu et al. found that the drug Disulfiram/copper could simultaneously inhibit NF-κB and Nrf2, induce activation of the ROS-JNK pathway, and selectively eradicate AML stem cells [27]. This evidence concerns the gene NFKB1 and acute myeloid leukemia.